EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial. Conference

cited authors

  • Cahill, Daniel P; George, Asha; Gilbert, Mark R; Chakravarti, Arnab; Stupp, Roger; Hegi, Monika; Brown, Paul; Jaeckle, Kurt A; Corn, Benjamin; Sulman, Erik P; Souhami, Luis; Werner-Wasik, Maria; Anderson, Bethany M; Mehta, Minesh; Aldape, Kenneth D

fiu authors

publication date

  • November 1, 2013

keywords

  • Life Sciences & Biomedicine
  • Science & Technology

Digital Object Identifier (DOI)

volume

  • 12

issue

  • 11